were transiently transfected with miR-31 mimics or miR-31 mimics and pWSLV-01-E2F2 plasmid and then subjected to different assays. (A) RT-PCR. Level of E2F2 mRNA was assessed by RT-PCR after transfection with pWSLV control or pWSLV-01-E2F2 into gastric cancer cells. (B) Western blot. Level of E2F2 protein was assessed after transfection with pWSLV control or pWSLV-01-E2F2 into gastric cancer cells. The relative protein levels were normalized to GAPDH and data were presented as mean ± sd. (C) Cell viability CCK8 assay. Cell viability was assessed after 24, 48, 72 and 96 h transfection with miR-31 mimics or miR-31 mimics and pWSLV-01-E2F2 plasmid into gastric cancer cells. Data were presented as mean ± sd of three independent experiments. *p < 0.05, **p < 0.01 and ***p < 0.001. (D) Apoptosis assay. Level of apoptosis was assessed after 48 h transfection with miR-31 mimics or miR-31 mimics and pWSLV-01-E2F2 plasmid into gastric cancer cells. Data were presented as mean ± sd of three independent experiments with duplicated samples. *p < 0.05. (E-F) Flow cytometric cell cycle assay. Cell cycle distribution was analyzed additional culture of 12 and 24 h after 48 h transfection with miR-31 mimics or miR-31 mimics and pWSLV-01-E2F2 plasmid into gastric cancer cells. (G) Tumor cell migration assay. Fluorescent images (×200) (left) and quantification (right) of migration level of SGC-7901 and MGC-803 cells after 24 h transfection withmiR-31 mimics or miR-31 mimics and pWSLV-01-E2F2 plasmid. Data were presented as mean ± sd, *p < 0.05.(H) Tumor cell invasion assay. Fluorescent images (left) and quantification (right) of invasion level of SGC-7901 and MGC-803 cells after 24 h transfection with miR-31 mimics or miR-31 mimics and pWSLV-01-E2F2 plasmid.Data were presented as mean ± sd, *p < 0.05.
